Market Report -- In Play () - MSN Money PDF Print

Affymax (AFFY) announces that enrollment has been completed in the remaining Phase 3 clinical trial of its lead investigational therapy, Hematide, ...

read more

 
Share |
Copyright © 2017 Global Dialysis. All Rights Reserved.